Study: MPR better for predicting death risk

06/29/2011 | MolecularImaging.net

Myocardial perfusion reserve is a more effective indicator of cardiac death risk than left ventricular ejection fraction and viability range in patients with ischemic heart disease who underwent a PET-driven procedure, according to a study published in the Journal of Nuclear Medicine. "The advantage of PET is that on top of viability, absolute myocardial perfusion can be measured. In addition, MPR can be assessed using vasodilator substances," the Dutch-led researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT